Showing results (31-40 of 104) with videos related to
Sort By:
Pageof 11
Journal of Leukocyte Biology|August 6, 2026
Complement System in Bone Inflammation and AutoimmunityAdrita Guha, Praneet Wahi, Girdhari LalMetabolic Brain Disease|May 28, 2021
Adiponectin: a potential target for obesity-associated Alzheimer's diseaseNikita Patil Samant, Girdhari Lal GuptaImmunotargets and Therapy|November 10, 2021
Key Activating and Inhibitory Ligands Involved in the Mobilization of Natural Killer Cells for Cancer ImmunotherapiesSurojit Karmakar, Pradipta Pal, Girdhari LalInflammopharmacology|March 16, 2025
Therapeutic effect of formononetin in 6-OHDA induced Parkinson disease in ratsTanvi Dayanand Pingale, Girdhari Lal GuptaThe European Journal of Neuroscience|August 28, 2020
Novel therapeutic strategies for Alzheimer's disease targeting brain cholesterol homeostasisNikita Patil Samant, Girdhari Lal GuptaNeurotoxicity Research|January 19, 2022
Avicularin Attenuates Memory Impairment in Rats with Amyloid Beta-Induced Alzheimer's DiseaseNikita Patil Samant, Girdhari Lal GuptaMetabolic Brain Disease|April 4, 2022
Gossypetin- based therapeutics for cognitive dysfunction in chronic unpredictable stress- exposed miceNikita Patil Samant, Girdhari Lal GuptaThe Journal of Pharmacy and Pharmacology|April 6, 2021
Novel therapeutic approaches for Parkinson's disease by targeting brain cholesterol homeostasisTanvi Dayanand Pingale, Girdhari Lal GuptaToxicology Mechanisms and Methods|December 12, 2023
Oleanolic acid-based therapeutics ameliorate rotenone-induced motor and depressive behaviors in parkinsonian male mice via controlling neuroinflammation and activating Nrf2-BDNF-dopaminergic signaling pathwaysTanvi Dayanand Pingale, Girdhari Lal GuptaToxicology Mechanisms and Methods|July 6, 2023
Acute and sub-acute toxicity study reveals no dentrimental effect of formononetin in mice upon repeated i.p. dosingTanvi Dayanand Pingale, Girdhari Lal GuptaPageof 11